Home » Clinical Trials » Leukemia » NCT04546893
NCT04546893

Safety and Efficacy Study of SL1904B CAR-T Cells for Relapsed or Refractory B-Cell Acute Lymphocyte Leukemia

Study Summary

This is an open, single-arm, clinical study to evaluate efficacy and safety of anti CD19 CAR-T cell in the treatment of recurrent or refractory B-ALL

Interested in this trial?

Submit an Inquiry

Interventions

CD19 CAR-TBIOLOGICAL
Biological: CD19 CAR-T; Drug: Cyclophosphamide,Fludarabine; Procedure: Leukapheresis;

Study Locations

FacilityCityStateCountry
Hebei yanda Ludaopei HospitalHebeiSanheChina
BeiJing Ludaopei HospitalBeijingYizhuangChina

Official Trial Information

View on ClinicalTrials.gov

Data sourced from ClinicalTrials.gov. Last updated: May 29, 2026